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Reproduction inmammals is under the control of the hypothalamic neuropeptide gonadotropin hormone-releasing hormone-1 (GnRH-
1). GnRH-1-secreting neurons originate during embryonic development in the nasal placode and migrate into the forebrain along
olfactory nerves. Gradients of secreted molecules may play a role in this migratory process. In this context, hepatocyte growth factor
(HGF) is a potential candidate, because it promotes cell motility in developing brain and has been shown previously to act as a motogen
on immortalized GnRH-1 neurons (GN11). In this study, the role of HGF and its receptorMet during development of the GnRH-1 system
was examined. GnRH-1 cells express Met during their migration and downregulate its expression once they complete this process.
Tissue-type plasminogen activator (tPA), a knownHGF activator, is also detected inmigratory GnRH-1 neurons. Consistent with in vivo
expression, HGF is present in nasal explants, and GnRH-1 neurons express Met. HGF-neutralizing antibody was applied to explants to
examine the role of the endogenous growth factor.Migration ofGnRH-1 cells andolfactory axonoutgrowthwere significantly reduced, in
linewith disruption of a guidance gradient. Exogenous application ofHGF to explants increased the distance that GnRH-1 cellsmigrated,
suggesting that HGF also acts as amotogen to GnRH-1 neurons. Functional experiments, performed on organotypic slice cultures, show
that creation of an opposing HGF gradient inhibits GnRH-1 neuronalmigration. Finally, tPA/:uPA/ (urokinase-type plasminogen
activator/) knock-out mice exhibit strong reduction of the GnRH-1 cell population. Together, these data indicate that HGF signaling
via Met receptor influences the development of GnRH-1.
Key words: GnRH-1; LHRH; HGF; migration; olfactory system; development
Introduction
Gonadotropin hormone-releasing hormone-1 (GnRH-1) regu-
lates anterior pituitary gonadotropes and, as such, is essential for
reproduction. GnRH-1-secreting neurons originate from the na-
sal placode (Wray, 2002) during embryonic development and
migrate to the hypothalamus apposed to olfactory-vomeronasal
nerves (Schwanzel-Fukuda et al., 1989; Wray et al., 1989). In
humans, several monogenic disorders leading to isolated hy-
pogonadotropic hypogonadism (IHH) are caused by disruption
ofGnRH-1 neuronal ontogeny/migration (Gonzalez-Martinez et
al., 2004). However, mutations in these genes do not account for
many individuals exhibiting IHH. This suggests that the full rep-
ertoire of molecular cues regulating the GnRH-1 migratory pro-
cess has not yet been identified.
Factors already shown to influence GnRH-1 neuron migra-
tion, either directly or indirectly via extension of olfactory axons
(Wray, 2002;Wierman et al., 2004; Tobet and Schwarting, 2006),
include neurotransmitters/neuropeptides (Fueshko et al., 1998;
Bless et al., 2000; Simonian and Herbison, 2001; Pronina et al.,
2003; Giacobini et al., 2004), surface molecules (Yoshida et
al., 1999; Gamble et al., 2005), and growth factors (Cronin et al.,
2004; Gill et al., 2004; Gill and Tsai, 2006). Guidance of the ax-
onal/migratory pathway is also an important prerequisite for es-
tablishment of the adult-like GnRH-1 cell distribution (Wray,
2002), and classical chemoattractants [(e.g., netrin-1 and stromal
cell-derived factor-1 (SDF-1)] or chemorepellents (e.g., reelin)
are distributed in gradients along the GnRH-1 migratory route
and participate in directing appropriatemigration (Schwarting et
al., 2001, 2004, 2006; Cariboni et al., 2005).
Hepatocyte growth factor (HGF) is a cytokine that, via its
receptor Met, exhibits mitogenic, motogenic, and chemoattrac-
tive activities in neuronal (Ebens et al., 1996; Maina et al., 1997;
Streit and Stern, 1997; Yamamoto et al., 1997; Caton et al., 2000;
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Ieraci et al., 2002; Gutierrez et al., 2004) and non-neuronal cells
(Stella and Comoglio, 1999; Urbanek et al., 2005; Son et al.,
2006). HGF and Met are widely distributed in developing brain
(Jung et al., 1994; Thewke and Seeds, 1996; Achim et al., 1997;
Thewke and Seeds, 1999; Korhonen et al., 2000); however, few
studies address the function(s) of Met signaling during brain
development. To date, HGF has been shown to have motogenic
effects on migrating cortical neurons (Powell et al., 2001, 2003;
Segarra et al., 2005). HGF is expressed in nasal embryonic mes-
enchyme with an increasing gradient toward the border between
the nose and telencephalon (Sonnenberg et al., 1993; Thewke and
Seeds, 1996). This pattern suggests thatHGF/Met signalingmight
impact developmental events in theGnRH-1/olfactory system. In
support of this,HGF exertsmotogenic and chemotactic effects on
theGN11 immortalizedGnRH-1 cell line (Giacobini et al., 2002).
To determine the role of HGF in the developing GnRH-1/
olfactory system, this study (1) characterized Met expression in
nasal regions during the period of GnRH-1 neuronal migration,
(2) perturbed HGF/Met signaling in two in vitro models (nasal
explants and slice cultures) in which primary GnRH-1 neurons
aremaintained and cellularmovement can be quantified, and (3)
assessed the impact of the lack of HGF activators [plasminogen
activators (PAs)] on the GnRH-1 neuronal population in PA
knock-out (KO) mice.
Materials andMethods
Animals
Experiments were conducted in accordance with current European
Union and Italian law, under authorization of the Italian Ministry of
Health, number 66/99-A.
CD-1 embryos (Charles River Laboratories, Milan, Italy) were har-
vested at embryonic day 11.5 (E11.5), E12.5, E14.5, and E17.5 (plug day,
E0.5) and used for RNA isolation, immediately frozen and stored
(80°C) until laser-capture microscopy, or postfixed [overnight; 4%
paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4] and cryo-
protected and then frozen and stored (80°C) until processing for im-
munocytochemistry. Tissue-type PA/ (tPA/):urokinase-type
PA/ (uPA/)-deficient mice and wild-type (WT) background con-
trol mice (C57B16/129sv) were provided by Prof. P. Carmeliet [Center
for Transgene Technology and Gene Therapy, Flanders Interuniversity
Institute for Biotechnology, University of Leuven, Leuven, Belgium)].
CD-1 postnatal day 10 (PN10) mice and adult knock-out and WT ani-
mals were anesthetized with an intraperitoneal injection of ketamine
(200 mg/kg) and perfused with 4% paraformaldehyde. The brains were
dissected and postfixed in the same fixative overnight at 4°C, cryopro-
tected in sucrose solutions, and then frozen and stored (80°C) until
processing for immunohistochemistry.
Nasal explants
Nasal regions were cultured as described previously (Fueshko andWray,
1994). Briefly, embryos were obtained from timed pregnant animals in
accordance with National Institutes of Health (NIH)/National Institute
of Neurological Disorders and Stroke guidelines and Animal Care and
Use Committee approval and with current European Union and Italian
law. Nasal pits of E11.5 staged NIH-Swiss embryos were isolated under
aseptic conditions in Gey’s balanced salt solution (Invitrogen Grand Is-
land, NY) enriched with glucose (Sigma-Aldrich, St. Louis, MO). Nasal
explants were adhered onto coverslips by a plasma (Cocalico Biologicals,
Reamstown, PA)/thrombin (Sigma-Aldrich) clot. The explants were
maintained in defined serum-free medium (SFM) (Fueshko and Wray,
1994) at 37°C with 5% CO2. From culture day 3 to day 6, fresh medium
containing fluorodeoxyuridine (8  105 M; Sigma-Aldrich) was given
to inhibit proliferation of dividing olfactory neurons and non-neuronal
explant tissue. The medium was changed to fresh SFM twice a week.
Transcript analyses
All primers were designed from published GenBank sequences and
screened using BLAST (basic local alignment search tool) to ensure spec-
ificity of binding. Primers were pretested on brain cDNA and thereafter
used throughout the described protocols at a concentration of 250 nM.
Amplified products were run on a 1.5% agarose gel.
Reverse transcription-PCR analysis
Total RNAwas isolated from noses and brains obtained from E11.5mice
using RNA STAT-60 (Tel-Test, Friendswood, TX) following the manu-
facturer’s protocol. Briefly, the tissue was homogenized (1 ml of RNA
STAT-60 per 50–100 mg of tissue), chloroform was added (0.2 ml/ml
homogenate), and the mixture was spun. To the aqueous layer, isopro-
panol was added (0.5 ml) to precipitate RNA. RNA pellet was washed
(75% ethanol), air dried, and resuspended (DEPC-treated water). Total
RNA from adult mouse brain served as positive control tissue. For the
reverse transcription (RT)-PCR, 0.5 g of each sample was used. First-
strand cDNAwas synthesized using the SuperScript III First-Strand Syn-
thesis System for RT-PCR (Invitrogen) following the manufacturer’s in-
structions. PCR was performed using 4 l of cDNA and the appropriate
oligonucleotides in 30 l PCRs using standard reaction buffer [(in mM)
10 Tris-HCl, pH 8.3, 50 KCl, and 1.5 MgCl2], 0.8 mM deoxynucleotide
triphosphate (Invitrogen) and 0.025 U/l REDTaq DNA polymerase
(Sigma-Aldrich). The following primers were used: 5-GGGA-
CTGCAGCAGCAAAGC-3 and 5-GTCTGAGCATCTAGAGTTT-
CC-3 for c-met amplification (Chan et al., 1988). For HGF, 5-
GGGGAATGAGAAATGCAGTCAG-3 and 5-CCTGTATCCATGGA-
TGCTTC-3 were used (Tashiro et al., 1990). The number of cycles and
the annealing temperature used for each primer pair were as follows: 25
cycles and 59°C for c-met; 30 cycles and 55°C forHGF.No products were
amplified in water or brain RNA not reverse transcribed.
Laser capture microdissection and RT-PCR on
tissue-specific regions
Laser capture microdissection (LCM) permits cells to be isolated (“cap-
tured”) from tissue sections for molecular analyses. In this study, olfac-
tory epithelium (OE), vomeronasal organ (VNO) epithelium, and lower
jaw were captured from E14.5 and E17.5 mouse frozen sections (see Fig.
1C,D) using a PALM LCM system (Zeiss, Thornwood, NY). The laser-
microdissected tissues were popped into a sterileMicrofuge cap contain-
ing 1 l of 0.1% Triton X-100 and subsequently centrifuged for 1 min at
7500 g (maximum) to relocate material to the bottom of a sterile tube.
Prime RNase inhibitor (7 l diluted 1:100 in DEPC-treated water; Ep-
pendorf, Hamburg, Germany) was added. Captured tissue was used to
synthesize first-strand cDNA using the SuperScript III First-Strand Syn-
thesis System for RT-PCR (Invitrogen) following the manufacturer’s in-
structions. Controls without reverse transcriptase were performed to
demonstrate the absence of contaminating genomic DNA. Brain total
RNA was also reverse transcribed and used as a positive control.
PCR was performed for III-tubulin (a general neuronal marker),
early B-cell factor 2 (EBF-2) [an olfactory transcription factor and thus
marker of olfactory/vomeronasal receptor neurons (Wang et al., 1997)],
c-met, and HGF at 40 cycles on a thermocycler (30 s denaturation at
94°C, 30 s annealing at 55–65°C, and 2 min elongation at 72°C). PCR
primer pairs were as follows: III-tubulin forward primer, 5-GAGGA-
CAGAGCCAAGTGGAC-3; III-tubulin reverse primer, 5-CAGGGC-
CAAGACAAGCAG-3; EBF-2 forward primer, 5-TGCAGTAGTT-
GCTAACAGTGG-3; EBF-2 reverse primer, 5-TTTCCAATGCTAG-
AAGCCTAAC-3.
Cell isolation and PCR analysis
Nasal explants were washed twice with 1 PBS (without Mg or Ca2)
and placed in 2 ml of the same solution. GnRH-1-like neurons were
identified by their bipolar morphology, association with outgrowing ax-
ons, and locationwithin the explant (see Fig. 4B). At two time points [4.5
and 28 d in vitro (div)], single GnRH-1 cells (n 5 for each in vitro stage)
were isolated from nasal explants using a micropipette (see Fig. 4A–C)
controlled by a micromanipulator (Narishige, Tokyo, Japan) connected
to an inverted microscope (IX51; Olympus Optical, New Hyde Park,
NY), cDNA was produced, and PCR amplification was performed as
described previously (Kramer et al., 2000; Giacobini et al., 2004). Briefly,
a single cell was lysed and reverse transcribed [AMV (avianmyeloblasto-
sis virus) and MMLV (Moloney murine leukemia virus)-reverse tran-
432 • J. Neurosci., January 10, 2007 • 27(2):431–445 Giacobini et al. • HGF Regulates GnRH-1 Neuronal Migration
scriptases; 37°C for 15 min; 65°C for 10 min] using an oligo-dT primer
(50OD/ml; pd(T)19–24). The cDNAwas end labeled with terminal trans-
ferase (37°C for 15min; 65°C for 10min). Subsequent PCR amplification
was performedusingAL1primers [ATTGGATCCAGGCCGCTCTGG
ACA AAA TAT GAA TTC (T)24] (Dulac and Axel, 1995) for 25 cycles in
a DNA Thermal Cycler (94°C for 1 min, 42°C for 2 min, and 72°C for 6
min, with 10 s of extension time at each cycle; PerkinElmer, Wellesley,
MA). After the first 25 cycles, fresh Taqwas added, and 25more cycles of
PCR were performed minus the 10 s extensions. The resulting product
was phenol-chloroform extracted and then ethanol precipitated, and an
aliquot was run on a 1.5% agarose gel. Total brain RNA (1 g) served as
a positive control. All cDNA pools were initially screened for GnRH-1
(correct cell phenotype), -tubulin, and L19 (two housekeeping genes,
microtubule and ribosomal) using PCR. All cells used in this study were
positive for all three transcripts. Primers sequences used were as follows:
GnRH-1, 5-GCTAGGCAGACAGAAACTTGC-3 and 5-GCATCTA-
CATCTTCTTCTGCC-3; -tubulin, described above; and L19, 5-
CCTGAAGGTCAAAGGGAATGTGTTC-3 and 5-GGACAGAGTCT-
TGATGATCTCCTCC-3. Each reaction mixture was generated as
described above, and 2l of each primer and 1l of template cDNAwere
added. The PCR program was as follows: 10 min at 94°C prerun; 30 s at
94°C, 30 s at 55°C or 65°C (depending on primers), and 2min at 72°C, for
35 cycles; and 10min at 72°C postrun. The same PCRprofile was used for
subsequent screening with the following primers: tPA forward primer
(5-AAGTTTGCACTGGGGACAAG-3), tPA reverse primer (5-
TCCCAAGAGTTGAGGAGTGTG-3), uPA forward primer (5-GTC-
TTCCATGTGATGCTCCA-3), and uPA reverse primers (5-AC-
CCAGTGAGGATTGGATGA-3). Specific bands were observed in total
E17.5 brain lanes, whereas no bands were seen in water lanes.
Immunocytochemistry
Primary antisera used were against GnRH-1 [SW-1, rabbit (Rb) poly-
clonal (Wray et al., 1988), kindly provided by Dr. S. Wray; LR-5, Rb
polyclonal, kindly provided byDr. R. Benoit,Montreal GeneralHospital,
Montreal, Quebec, Canada; SMI41,mousemonoclonal antibody (Stern-
berger Monoclonals, Baltimore, MD)], HGF (#AF294-NA, goat poly-
clonal; R & D Systems, Minneapolis, MN) Met (#SP260 and #H-190,
rabbit polyclonal, and #B-2, mouse monoclonal IgG; Santa Cruz Bio-
technology, Santa Cruz, CA), peripherin (#AB1530, rabbit polyclonal;
Millipore, Billerica, MA), neural cell adhesion molecule (NCAM;
#C9672, mouse monoclonal IgG; Sigma-Aldrich), and tPA (#ASMTPA,
rabbit polyclonal; Molecular Innovations, Southfield, MI).
Mouse tissue sections or nasal explants were immunocytochemically
stained as described previously (Fueshko and Wray, 1994; Wray et al.,
1994). Mouse embryos and postnatal and adult brains were cryosec-
tioned respectively at 16m(embryos) and free-floating at 30m(post-
natal or adult brains). These sections and explants were fixed with 4%
formaldehyde for 1 h before immunocytochemistry. Briefly, sections or
nasal explants were washed in PBS, incubated in 10% NGS/0.3% Triton
X-100 (NGS/Tx-100; 1 h), washed several times in PBS, and placed in
primary antibody (overnight at 4°C). The next day, tissues were washed
in PBS, incubated in biotinylated secondary antibody [1 h; 1:500 in PBS/
0.3% Triton X-100; goat anti-rabbit biotinylated (GAR-Bt; Vector Lab-
oratories, Burlingame, CA); goat anti-mouse biotinylated (GAM-Bt;
Millipore)], and processed using a standard avidin–biotin–horseradish
peroxidase/3, 3-diaminobenzidine (DAB) protocol. For double immu-
noperoxidase staining, the chromogen for the first antigen–antibody
complex was DAB [brown precipitate (Kramer and Wray, 2000)],
whereas the chromogen for the second antigen–antibody complex was
SG substrate (blue precipitate; Vector Laboratories). Primary antisera
dilutions were as follows: anti-GnRH-1 (SW-1; 1:3000), anti-peripherin
(1:2000), anti-Met (#SP260 and # H-190; 1:200). For double-
immunofluorescence experiments, primary antisera were diluted as fol-
lows: anti-GnRH-1 (SW-1, 1:1000; SMI41, 1:3000), anti-NCAM (1:60),
anti-HGF (1:10), anti-Met (#SP260 and # H-190; 1:100), and anti-tPA
(1:500). Sections or nasal explants were incubated overnight (4°C) in a
mixture of primary antibodies diluted in NGS/Tx-100 and visualized
using Alexa Fluor 488 and Alexa Fluor 568 conjugated secondary anti-
bodies (1:500; Invitrogen). Anti-Met and anti-HGF antisera were incu-
bated for two nights at 4°C.
When two polyclonal primary antibodies were used (anti-Met/SW-1
and anti-tPA/SW-1), staining of the first antigen–antibody complex was
performed with goat anti-rabbit Alexa Fluor 488 (1:500; Invitrogen) sec-
ondary antibody. This step was followed by a blocking reaction with an
anti-rabbit Fab fragment (Jackson ImmunoResearch Laboratories, West
Grove, PA) (Giacobini et al., 2004) for 1 h (RT), followed by PBS washes,
fixation (4% formalin for 30min), andmore PBS washes before applica-
tion of the second primary antibody, which was visualized with conju-
gated fluorescent goat anti-rabbit cyanine 3 (Cy3; 1:800; Jackson Immu-
noResearch Laboratories).
E12.5 slice cultures were fixed with 4% PFA for 1 h and processed for
immunohistochemistry. To detect GnRH-1 immunoreactivity, slices
were incubated at 4°C for five nights with LR-5 antibody diluted 1:4000
in PBS containing 10% NGS and 1% Tx-100. For secondary antibody
processing, slices were washed several times with PBS for 1 h before
incubation overnight at 4°C with goat anti-rabbit Cy3 (1:500; Jackson
ImmunoResearch Laboratories).
Specimen were mounted in DABCO (1,4-diazabicyclo[2.2.2]octane;
Sigma-Aldrich) and observed with a laser-scanning Olympus Fluoview
confocal system (Olympus Optical).
Functional assays
Nasal explant. To determine the function of HGF in the developing
olfactory/GnRH-1 systems, pharmacological perturbations were per-
formed, and olfactory axon outgrowth and GnRH-1 cell migration were
quantified. Explants in experimental groups were maintained in SFM
containing either a blockingHGF antibody (5g/ml; #AF294-NA; R&D
Systems) or 25 ng/ml human recombinant HGF (Sigma-Aldrich). Drug
concentrations were based on data from previous migrational studies
(Powell et al., 2001; Giacobini et al., 2002). Nasal explants were treated at
3 div with pharmacological agents for 72 h. Control explants were main-
tained in SFM that was changed, as in the treatment groups, at 3 and 6
div. At 7 div, explants were processed for double-label immunocyto-
chemistry for GnRH-1/peripherin (see above), and then theGnRH-1 cell
migration as well as the maximum olfactory axon outgrowth were quan-
tified as described below. Treatments performed at 1 div (for 72 h) did
not induce any significant change in the parameters examined compared
with control cultures (data not shown).
Quantification of GnRH-1 cell number, migration, and olfactory fiber
outgrowth. For each explant, the number of GnRH-1-immunopositive
cells was counted on the main tissue mass, as well as in the periphery of
the explant (Fueshko et al., 1998; Giacobini et al., 2004). The main tissue
mass contained the nasal pit/olfactory epithelial region, surrounding
mesenchyme, and nasal midline cartilage (see Fig. 3, schematic). The
periphery refers to the area surrounding the main tissue mass into which
cells had spread and/or migrated. Data are presented as mean  SEM.
Quantification of GnRH-1 cell migration and olfactory axon outgrowth
was performed digitizing the stained explant. Images were taken under
an Olympus IX50 inverted microscope (Olympus Optical) equipped
with a CCD camera CoolSNAP-Pro (Media Cybernetics, Silver Spring)
and images edited with Image-Pro Plus software (Media Cybernetics).
For cell migrational measurements, a caliber with a series of concentric
arcs separated by a uniform distance (200 m) was overlaid on the dig-
itized image. The total number of cells in each zone of the periphery of
the explant was recorded via computer-assisted analysis (Image-Pro Plus
software; Media Cybernetics) (see Fig. 6). In general, under all treatment
conditions, the number of GnRH-1 cells decreases as a function of dis-
tance from the main tissue mass. GnRH-1 cell migration was calculated
as the distance from the main tissue mass edge to the outer sector of the
periphery.
For fiber outgrowth measurements, the distance from the border of
the explant at which themajority of peripherin-positive fibers ended was
recorded; this method was chosen because the complex nature of the
fiber network prevented quantification of individual fiber lengths. A
mean distance for fiber outgrowth was obtained for each treatment
group, and values were reported as the mean  SEM. All experiments
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used explants generated by different individuals on multiple culture
dates.
Statistical analysis of fiber outgrowth was performed with a one-way
ANOVA followed by Fisher’s least significant difference (LSD) post hoc
analysis ( p  0.05) using the statistical software SPSS 12.0 (SPSS, Chi-
cago, IL). Amean totalGnRH-1 cell number (inside the explant and/or in
the periphery)was obtained for each treatment group and analyzed using
a one-way ANOVA. These values were taken as an indication of GnRH-1
cell survival. Data for cell movement were compared for SFM and exper-
imental groups by constructing contingency tables and applying the  2
test for independence. This nonparametric analysis was chosen because
zonal distance (200 m grouping) was used instead of continuous mea-
surements, and the number of observations per treatment (culture num-
ber) was not identical. A stringent p value of 0.001 was chosen for signif-
icance in these experiments.
HGF-expressing cells
To obtain HGF clones in which expression of murine HGF can be spe-
cifically induced by doxycycline (Dox), we adopted the tetracycline
(Tet)-Off technology described byGossen andBujard (1992). Themouse
HGF cDNA was inserted in the bidirectional pBI response plasmid con-
taining enhanced green fluorescent protein (EGFP) as a reporter gene
(Baron et al., 1995), which makes it possible to trace cells expressing the
transgene by EGFP imaging. The plasmid was introduced into stable
Madin-Darby canine kidney (MDCK) Tet-Off cells, and clones resistant
to blasticidinwere selected and expanded. TheHGF cDNA construct was
amplified from murine HGF plasmid (a kind gift from Dr. W. J. LaRo-
chelle) using the PlatinumPfx polymerase (Invitrogen) and the following
oligonucleotides (Sigma-Aldrich): 5-TTGCACGCGTCCACCAT-
GATGTGGGGGACCAAAC-3 and 5-TTACACGCGTGTTAACTTA-
CTTTCCAAGTCGGTTCATCTCTATGTCTGTATACAACTTGTATG-
TCAAAA-3. The obtained cDNA encoded the full-length HGF se-
quence, flankedwithMluI sites and fused to aKozak consensus ribosome
binding site at theN terminus and to oligonucleotides encoding the 11 aa
vesicular stomatitis virus glycoprotein G (VSVG) tag at the C terminus.
The fidelity of theHGF insert was verified by sequencing (MWGBiotech,
Ebersberg, Germany). The insert was then ligated into the MluI site of
pBI-EGFP (Clontech, Mountain View, CA) to generate the HGF-TRE-
EGFP responder plasmid. MDCK cells expressing the tetracycline trans-
activator (tTA) under cytomegalovirus promoter (MDCK-Tet-Off cell
line; Clontech) were transfected with pBI-HGF-TRE-EGFP plasmid and
a blasticidin selection plasmid. Exponentially growing MDCK-tTA cells
were seeded 24 h before DNA transfer on 10 cm tissue culture dishes and
transfected using Lipofectamine 2000 (Invitrogen). Cells were selectively
grown in growth media containing 5 g/ml blasticidin (Sigma-Aldrich)
for 2 weeks. Different resistant clones were picked by selective trypsiniza-
tion and checked for inducible expression of EGFP reporter gene and
HGF by in vivo imaging of EGFP and scatter assay of conditioned me-
dium, respectively (see Fig. 8). Clone n.1, which expresses high levels of
EGFP- and HGF-transfected protein, was selected for this study.
Tet-Off cells were grown in monolayer at 37°C in 5% CO2, in DMEM
(Invitrogen) containing 4500 mg of glucose, 1 mM sodium pyruvate, 2
mM glutamine, 100 g/ml streptomycin, and 100 U/ml penicillin, and
supplemented with 10% fetal bovine serum (FBS; Invitrogen). To
turn off EGFP and HGF expression, Dox (1 g/ml) was added to the
culture medium. Cells within six passages were used throughout the
experiments.
Western blot
For Western blotting analysis, equal amounts of proteins (100 g)
were boiled in sample buffer (33% bromphenol blue, 33% -mercapto-
ethanol, and 33% glycerol) and subjected to 7% SDS-PAGE. Proteins
were blotted onto Hybond-C Extra membrane (GE Healthcare, Piscat-
away, NJ). Filters were probed with specific primary antibodies: 1:500
anti-mouse met #B-2 (Santa Cruz Biotechnology), 1:500 HGF goat anti-
serum (R & D Systems), 1:1000 P5D4 Mab (monoclonal antibody)
mouse antiserum raised against the 11 aa C terminus of VSVG (Crepaldi
et al., 1997) to detect HGF protein in lysates fromMDCK cells expressing
taggedHGF. In the latter case, total extracts were run under nonreducing
conditions. Immunoblots were developed with an enhanced chemilumi-
nescence kit, ECL (GE Healthcare).
Cell scattering assay
A classic scatter assay, using Met-expressing MDCK epithelial cells
(Stoker et al., 1987; Montesano et al., 1991; Powell et al., 2001), was used
to determine whether culture medium conditioned (CM) by nasal ex-
plants or Tet-Off cells contained functional HGF. MDCK cells were cul-
tured in the same medium used for transfected cells, supplemented with
5% FBS (Invitrogen). MDCK cells (8000) were plated onto glass cover-
slips. The following day, discrete colonies were formed and then treated
with known concentrations of HGF or CM (diluted 1:1 in fresh culture
medium) collected fromnasal explants at 3 div (medium conditioned for
3 d) or from Tet-Off cells cultured in the absence or presence of Dox
(medium conditioned for 5–7 d). In a subset of experiments, a blocking-
function HGF antibody was added (5 g/ml). Twenty-four hours later,
the MDCK cells were washed in PBS, fixed with 4% formaldehyde, and
stained either by the nuclear cell dye 4,6-diamidino-2-phenylindole
(DAPI) or by crystal violet. Images were taken under an Olympus IX50
inverted microscope (Olympus Optical) equipped with a CCD camera
CoolSNAP-Pro (Media Cybernetics). Quantitative analysis of the scatter
response was performed on digitized images that were overlaid on circles
with a diameter of 80m (see Fig. 5E). MDCK cells were counted within
each circle superimposed on areas in which cells were detectable. In
general, the number of cells within these counting frames decreases as a
function of cell scatter. Values were reported as the mean  SEM.
ANOVA followed by Fisher’s LSD post hoc analysis was used to compare
groups ( p 0.001).
Tet-Off cell aggregates
Tet-Off cells were collected by trypsinization, resuspended in 20 l of
growth-factor free Matrigel (BD Biosciences, San Jose, CA) diluted 1:1
with the culture medium and seeded in 20 l drops of this solution
(200,000 cells for both cell lines, with or without Dox) on the lid of a
culture dish. The lid was then turned upside down and incubated at 37°C
for 10–20 min. As the droplets of cell aggregates were set, they were cut
into four pieces (each one containing50,000 cells) with a sterile blade.
Embryonic slice cultures
Timed pregnant CD-1mice (Charles River Laboratories) were harvested
at E12.5 to generate whole-head organotypic slice cultures following the
procedures described previously (Tobet et al., 1996; Bless et al., 2000).
Briefly, embryonic heads were embedded in 8% low-gelling-temperature
agarose (type VIIa; Sigma-Aldrich), and parasagittal sections were cut at
300 m using a vibratome and placed into Petri dishes containing ice-
cold dissection medium (Leibovitz’s L-15; pH 7.4; Invitrogen). These
slices were moved carefully to avoid any torsion, stretch, or compression
trauma, which may compromise the migration of GnRH-1 neurons in
vitro.
Day 0. E12.5 organotypic slices went through all of the steps described
above until the point of plating. At this point, the tissuewas fixedwith 4%
PFA and stained for GnRH-1 as described above.
Day 1. All slices that were subjected to functional treatments were
maintained in culture for 24 h. Organotypic slices were plated onto 30
mmMillicell inserts (Millipore) coatedwith a thin layer of growth factor-
free Matrigel (BD Biosciences). The inserts were placed into dishes con-
taining 2 ml of culture medium. This medium was partially removed
from the wells, such that only a thin layer of liquid remained covering
each slice. The slices were maintained in a humidified incubator (37°C)
for 1 d. The slice culture medium consisted of Neurobasal medium (In-
vitrogen) supplemented with B27 supplement (Invitrogen), 0.5 mM glu-
tamine (Invitrogen), and 25 g/ml gentamycin (Invitrogen).
Aggregates of Tet-Off cells (50,000 cells) expressing EGFP–HGF (with
or without Dox) were placed at the rostral tip of the nasal region at 0 div.
After 24 h, organotypic cultures were fixed with 4% PFA and stained for
GnRH-1 as described above. Slices were used for the quantitative analy-
ses if they contained at least 250 GnRH-1-immunoreactive (GnRH-1-ir)
neurons and if the connection between the nasal compartment and the
brain appeared intact.
Data analysis. Quantitative analysis of GnRH-1 neurons was per-
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formed as a function of location with GnRH-1 cells assigned to one of
two regions (nasal region andCNS). Total number of cells was calculated
for each slice and combined to give group means SEM. Given that the
total number of GnRH-1 neurons per slice did not change between treat-
ment groups (see Results), GnRH-1 cell distribution is presented as the
average percentage of labeled cells located in the nose or in the CNS
under different treatment conditions. Where a significant overall one-
way ANOVA was found ( p 0.05), post hoc comparisons using Fisher’s
LSD test were performed to further clarify sig-
nificant differences between individual treat-
ment groups ( p 0.05).
Quantitative analysis of GnRH-1 neurons
in tPA/:uPA/mutant animals
Serial sagittal sections (30m; four series) from
tPA/:uPA/ and WTmice (n 3 for each
group) were cut and labeled for GnRH-1 as de-
scribed above (GnRH-1 immunoreactivity vi-
sualized using DAB substrate). Total numbers
of GnRH-1 cells were calculated in each brain
and combined to give group means  SEM.
Data for GnRH-1 cell number betweenWT and
knock-out animals were compared by one-way
ANOVA followed by a Fisher’s LSD post hoc
test. ANOVAdatawere considered significantly
different if p 0.05.
Results
HGF/Met expression in the developing
nasal regions
To identify whether Met and HGF were
expressed prenatally in nasal regions, nose
tissue was removed at E11.5, when
GnRH-1 neurons are in the presumptive
VNO, and RT-PCR experiments were per-
formed (Fig. 1A,B). Both c-met and HGF
transcripts were detected in all samples
(E11.5 head, E11.5 nose, and adult brain)
but water. Western blot analysis was used
to document protein expression in embry-
onic nose tissues (Fig. 1B, right). HGF is
initially biosynthesized and secreted in a
biologically inactive single-chain form
(pro-HGF; 100 kDa) and is subse-
quently activated by specific serine pro-
teases into an -chain (69 kDa) and a
-chain (34 kDa) form containing a total
of five glycosylation sites (Nakamura et al.,
1989). E12 nose tissues and E16 head ex-
tracts (positive control) showed distinct
bands corresponding to the -chain (Fig.
1B, right). Protein bands of -chain were
not single, showing that these proteins
were glycosylated heterogeneously. The
top band corresponds to the glycosylated
form (69 kDa), whereas the bottom band
represents the nonglycosylated -chain
(53 kDa). E12 nose protein extracts con-
tained a barely detectable band of inactive
single-chain HGF (100 kDa), indicating
that most HGF in these tissues is the
activated form. A 145 kDa Met-
immunoreactive band was also evident in
the same protein extracts (Fig. 1B, right).
These results indicate that at E12, both ac-
tive HGF and its receptor are expressed in
the nasal compartment.
To determine the expression of HGF and c-met transcripts in
more defined regions of the nasal compartment, LCM was used.
Single punches from olfactory epithelium (OE) and VNO were
removed at E14.5, and RT-PCR experiments were performed
(Fig. 1C–E). This embryonic age corresponds to a stage of robust
axonal outgrowth from the OE to the developing olfactory bulb.
Figure 1. Nasal regions express HGF and its receptor Met during embryonic development. Schematic of an E11.5–E12.5 head
[fb, OE, presumptive VNO, tongue (t), and third ventricle (III) are depicted]. The dashed line indicates the boundary between nose
and brain and represents the region taken for nasal RNA isolation in B. B, Gel documentation of products produced by RT-PCR
amplificationusing specific primers for c-met andHGF. Total RNAwas isolated fromnose andwholeheadat E11.5. Adult brainwas
used as positive control tissue. Transcripts for both c-met and HGF were detected in all samples but water. Western blot analysis
showed that HGF is expressed in its active form in protein extracts of E12 noses as well in whole heads of E16, used as positive
control tissue. Western blot was run under reducing conditions. Met expression was also detected in the same samples. C, D,
Photographsof E14.5 sagittal sections after LCM.Representativepictures showexamples ofmicrodissectedOE (C) andVNO (D). No
other tissue was removed from the nasal section, and the remaining tissue was intact after the capture procedure. E, Total RNA
isolated from dissected regions was subjected to RT-PCR. A fragment of the expected size (519 bp) was detected for c-met in the
OE and inVNO. Expression of the olfactorymarker EBF-2 (165bp) confirmed themorphology of thedissected tissue. PCRusingHGF
primers showed the expected amplicon (314 bp) in the positive control lane (CNTR; E17.5whole-embryo extracts) but not in OE or
VNO.NoPCRproductwas observed in reactions that omitted either reverse transcriptase or startingmaterial (water).F,G, Sagittal
section of an E14.5 mouse nose double stained for NCAM (expressed by olfactory/vomeronasal axons; F ) and Met (G). Met
immunoreactivity is distributed in the developing OE and VNO structures and along the olfactory/vomeronasal fibers. G, Inset,
Colocalization between the twoantigens.MW,Molecularweight; OB, olfactory bulb. Scale bars: (inC)C,D, 30m; (inF )F,G, 100
m; G, inset, 22m. Asterisks indicate laser-captured areas.
Giacobini et al. • HGF Regulates GnRH-1 Neuronal Migration J. Neurosci., January 10, 2007 • 27(2):431–445 • 435
After reverse transcription of the mRNA,
PCR with specific primers for -tubulin
(positive control) and the olfactory
marker Olf/EBF-2 was performed (Fig.
1E). A 158 bp band corresponding to
-tubulin (data not shown) and a 165 bp
band corresponding to EBF-2 product
were detected in both OE and VNO, sup-
porting the olfactory nature of the laser-
captured tissues (Wang et al., 1997). Prod-
ucts for c-met were found in theOE as well
as in the VNO section, with a stronger ex-
pression in the latter tissue (Fig. 1E). HGF
transcript was not detected in the OE and
VNO regions, whereas a specific band of
correct size was found in the control lane
(E17.5 whole-embryo extracts) (Fig. 1E).
These LCMRT-PCRdata are in agreement
with previous in situ hybridization studies
showing c-met and HGF mRNAs in the
developing murine OE and in the sur-
rounding nasal mesenchyme, respectively
(Thewke and Seeds, 1996).
To determine whetherMet protein was
expressed by the developing olfactory ax-
ons, double-label immunofluorescence
was performed for Met and NCAM, a
marker of the olfactory/vomeronasal sys-
tem (Calof andChikaraishi, 1989;Miragall
et al., 1989). Met and NCAM expressions
overlapped on fibers emerging from the
VNO at E14.5, as shown by single confocal
planes (Fig. 1F,G, inset), and were coex-
pressed in olfactory/vomeronasal axon
bundles from the nasal tract to the medial
surface of the forebrain throughout the
analyzed stages (E12.5–E17.5). Because of
low signal-to-noise levels in brain, wewere
unable to detect specific immunoreactivity for Met along the
caudal nerve that GnRH-1 cells follow into the ventral forebrain
(Yoshida et al., 1995).
Migrating GnRH-1 neurons express Met
Immunohistochemistry indicated Met protein expression in the
presumptive VNO epithelium as well as in cells migrating out of
this structure into the nasal mesenchyme (Fig. 2A, arrows) and
along vomeronasal fibers of E12.5 embryos (Fig. 2A, arrow-
heads). To establish whether Met-positive cells were GnRH-1-
migrating neurons, double immunohistochemical stainings were
performed. Double-labeling experiments for GnRH-1 and Met
indicated that, at E12.5 (Fig. 2B,C) and E14.5 (data not shown),
themajority of GnRH-1 neuronswereMet immunopositive (Fig.
2B,C, arrows), as revealed bymerged single confocal planes (Fig.
2C, inset, arrows). Once within the brain, it was difficult to de-
termine whether GnRH-1 neurons maintained Met expression,
because of the high level of expression of this receptor in other
CNS cells (data not shown). However, at postnatal day 10, Met
expression was broadly downregulated throughout the brain, al-
though there was evidence of discrete Met staining within the
hypothalamus (Fig. 2D, arrowheads). This corresponds to a stage
when the GnRH-1 migratory process is over. Double labeling for
GnRH-1 (Fig. 2D–F, arrows) and Met (arrowheads) at PN10
revealed no coexpression between the two antigens, as shown by
single confocal planes (Fig. 2E,F). Thus, Met immunoreactivity
is associated with migrating GnRH-1 neurons, being downregu-
lated once these cells complete their migration.
HGF/Met expression in nasal explants
The HGF/Met expression pattern observed in nasal regions dur-
ing development together with results from previous studies
(Sonnenberg et al., 1993; Thewke and Seeds, 1996; Powell et al.,
2001) suggest thatHGFmayhave a role in regulating theGnRH-1
migratory process. In this context, nasal explants represent a
valuable tool to separate spatial from temporal cues and focus on
the properties of GnRH-1 neurons by controlling extracellular
influences (Fueshko and Wray, 1994; Giacobini et al., 2004). It
has been shown previously that the migrational pattern of
GnRH-1 neurons observed in vivo reproducibly occurs in nasal
explants in vitro; with a shift in location of the GnRH-1 cell pop-
ulation from the olfactory pit epithelia (OPEs) to the edge of the
main tissue mass occurring from 1 to 3 div and continuing to
more distant sites from 3 to 7 div (Fueshko and Wray, 1994).
To use nasal explants for functional studies, we first verified
that this system retained expression of HGF and its receptor sim-
ilar to the in vivo expression pattern. At 3 div, the majority of
GnRH-1 neurons are located in the inner tissue mass of the ex-
plant, but some have started to migrate out into the periphery of
the explant (Fig. 3B, arrows). At this stage, HGF immunoreactiv-
Figure 2. Met receptor expression in GnRH-1 neurons correlateswithmigration.A–C, Sagittal sections of E12.5mouse immu-
nostained with indicated antibodies. A, Met-immunoreactive cells emerged from the developing VNO andmigrated through the
olfactorymesenchyme (arrows) toward the forebrain.Met staining is also evident along the vomeronasal fibers coming out of the
VNO.Arrowheads indicateMet-ir vomeronasal fibers.B,C, Double-label immunofluorescence forMet (red;B) andGnRH-1 (green;
C) indicates that migrating GnRH-1 neurons spanning across the nasal regions coexpress Met (C, inset, arrows). D–F, Coronal
section of hypothalamic area of a PN10 mouse double labeled for GnRH-1 (red; arrows) and Met (green; arrowheads). E, F,
High-power confocal analysis showed that GnRH-1-immunoreactive cells and fibers do not colocalize with Met-
immunopositive elements at this stage. III, Third ventricle. Scale bars: A, 30m; (in B) B, C, 10m; (in B) D, 15m; C,
inset, 10m; (in E) E, F, 8m.
436 • J. Neurosci., January 10, 2007 • 27(2):431–445 Giacobini et al. • HGF Regulates GnRH-1 Neuronal Migration
ity was robustly expressed in the submucosa adjacent to the OPE,
in the midline cartilage, and in mesenchymal cells located at the
border between the inner tissue mass and the periphery, coincid-
ing with the site at which GnRH-1 neurons and olfactory axons
exit (Fig. 3C, asterisks). This latter region corresponds to the
frontonasalmesenchyme, also known as nasal/forebrain junction
(n/fb J) in vivo. The expression pattern of
Met receptor was then examined at the
same in vitro stage. Met coexpressed with
migrating GnRH-1 neurons as well as with
the olfactory neurons in the OPE (Fig. 3D,
arrowhead). At 7 div,GnRH-1neurons are
located in the periphery of nasal explants
in close association with the olfactory fi-
bers. At this stage, themajority of GnRH-1
neurons expressed Met (Fig. 3E,F, arrow-
heads), although some Met-positive/
GnRH-1-negative cells were detected as
well (Fig. 3E, arrows). In addition, olfactory
axons, along which GnRH-1 neurons mi-
grated, exhibited Met staining (Fig. 3E).
Hence, consistent with in vivo results, Met
receptor demarcated the olfactory system
and themigrating GnRH-1 cell population.
tPA is expressed in migrating GnRH-1
neurons in vitro
tPA and uPA are serine proteases that, in
addition to other proteases related to
blood coagulation factor XII, have been
shown to cleave and activate pro-HGF
(Mars et al., 1993). Moreover, PAs expres-
sion is most pronounced during cell mi-
gration and axonal outgrowth processes in
the developing nervous system (Seeds et
al., 1997). Thus, tPA and uPA expression
by GnRH-1 neurons was evaluated in
vitro.
Single GnRH-1 cells were removed
from nasal explants at 4.5 and 28 div (Fig.
4A–C, arrows), two in vitro stages repre-
sentative of GnRH-1 cells during migra-
tory and postmigratory phases, respec-
tively (Fueshko and Wray, 1994). cDNA
pools were examined for tPA and uPA
transcripts by single-cell RT-PCR. At 4.5
div, the majority of GnRH-1 cells (four of
five) expressed tPA but not uPA tran-
scripts. By 28 div, all GnRH-1 neurons
(n 5) were negative for both transcripts
(Fig. 4D). Double immunofluorescence
for GnRH-1 and tPAwas performed in na-
sal explants at 4.5 div (Fig. 4E). These ex-
periments revealed coexpression of the an-
tigens (Fig. 4E, arrows, inset) as well as
expression of tPA along olfactory axons,
confirming previous in situ hybridization
studies (Thewke and Seeds, 1996). Thus,
immunocytochemical experiments con-
firmed single-cell PCR results showing
that tPA is expressed in GnRH-1 cells in a
temporal window limited to the neuronal
migratory process.
Functional analyses
Nasal explants release bioactive HGF in the culture medium
The expression analyses demonstrate that HGF protein is present
in nasal regions both in vivo and in vitro with a temporal and
Figure3. HGFandMet expression innasal explantsmimics expression in vivo.A, Schematic of a nasal explant removed froman
E11.5mouse andmaintained in serum-freemedia for 7 d. Ovals represent OPEs; in the center is the nasal midline cartilage (NMC)
and surroundingmesenchyme (M). GnRH-1 neurons (dots)migrate fromOPE following olfactory axons to themidline and off the
explant into the periphery. B, C, Double immunofluorescence was performed using antibodies to GnRH-1 (green; B, C) and HGF
(red; C) at 3 div. Note that GnRH-1 neurons at this stagemigrate off the OPE through the nasal mesenchyme and emerge into the
periphery of the explant. Dashed lines indicate theborder between the inner tissuemass and theperiphery (B).C, HGF is expressed
in the submucosa lining theOPE structures, in thenasalmidline cartilage, and in then/fb Jmesenchyme (asterisks).D, OPE in inner
tissue mass of a 3 div nasal explant stained for GnRH-1 (green) and Met (red). Met was robustly expressed in the olfactory
epithelium. In addition, a GnRH-1 neuron migrating out of the OPE clearly expressed Met (arrowhead). E, At 7 div, a large
population of GnRH-1 neurons is located in the periphery of the explant. The majority of GnRH-1 neurons coexpressed Met
receptor (bottom inset, arrowheads). Few GnRH-1-positive/Met-negative cells were also detected (top inset, arrow), as well as
migrating cells, which were positive for Met but not for GnRH-1 (bottom inset, arrow). Met immunoreactivity was also evident
along theolfactory axonnetwork.F, Nasal explant at 7div triple stained for theamidated formofGnRH-1 (antibodySMI41; green),
Met (red), and DAPI (nuclear dye; blue). Three-dimensionally reconstructed GnRH-1-positive cells colabeledwithMet are shown.
Reconstructed orthogonal projections are presented as viewed in the x–z (bottom) and y–z (right) planes. Scale bars: (in B) B, C,
100m; D, 20m; E, 30m; E, insets, 10m; F, 4m.
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spatial pattern to impact GnRH-1/olfac-
tory system development. The form of
HGF observed in E12 noses by Western
blots is indicative of a biologically active
protein. To test whether the embryonic
nasal region is able to release functional
HGF, nasal explant CMwas collected, and
a typical scatter assay was performed, tak-
ing advantage of the Met-expressing
MDCK cell line. In the absence of HGF,
these cells grow in compact colonies (Fig.
5A, inset, arrows). The addition of 10
ng/ml HGF for 48 h to MDCK cultures
induced a typical change inmorphology of
MDCK cells and a scatter response result-
ing in cell dispersion (Fig. 5B, inset, ar-
rows). CM from 3 div nasal explants also
enhanced migration capacity (Fig. 5C),
which was blocked by the addition of
HGF-neutralizing antibody (5 g/ml)
(Fig. 5D). The scatter response was quan-
tified by measuring the number of MDCK
cells contained within each counting
frame (see Materials and Methods) (Fig.
5E, arrows). This number decreases as a
function of cell dispersion after increased
migratory activity. Quantification of the
scatter response showed more than a 50%
reduction in the cell number contained
within each counting frame in HGF- and
CM-treated groups compared with con-
trol conditions (Fig. 5E).
Anti-HGF disrupts GnRH-1 neuronal
migration and olfactory
axon outgrowth
To determine the role of endogenousHGF
on GnRH-1/olfactory system develop-
ment, the explants were treated with anti-
HGF (5 g/ml). The same concentration
of this antibody has been used in previous
studies to neutralize the activity of HGF
(Powell et al., 2001; Giacobini et al., 2002).
Nasal explantswere treated from3 to 6 div,
a temporal window characterized by mas-
sive olfactory axonal growth and GnRH-1
neuronal migration from the inner tissue
mass to the periphery of the explant
(Fueshko andWray, 1994). Nasal explants
were fixed at 7 div and stained for GnRH-1
and peripherin, which stains the olfactory
system (Fig. 6A). No significant differ-
ences were found in total number of
GnRH-1 cells inside the inner tissue mass
(control, 64  9; n  18; anti-HGF treat-
ment, 74 9; n 20) or in the periphery
of the explant (control, 176 22; n 20;
anti-HGF treatment, 150  18; n  21).
No changes in GnRH-1 cell number after
treatment suggests thatmitogenic and sur-
vival effects of HGF on GnRH-1 neurons
are unlikely. However, application of anti-
HGF severely stunted the migration of
Figure 5. Nasal explants release functional HGF. A–D, Images show MDCK cells that were plated at identical densities and
stainedwith nuclear dye DAPI (white).A, In SFM conditions, MDCK cells organized in typical colonies (inset; DAPI and bright field;
arrows point to individual cells in a cluster). B, In the presence of 10 ng/ml HGF, MDCK cells dispersed (scatter) and moved away
from each other (inset). Conditioned medium from 3 div nasal explants induced scatter response of MDCK cells (C), which was
prevented by the addition of HGF-neutralizing antibody (D). E, Quantitative analysis of the scatter response was performed on
digitized images that were overlaid on circles (counting frames) with a diameter of 80 m (see Materials and Methods). The
number (No) of cellswithin the counting framesdecreases as a function of cell-scatter response [n4wells counted for SFM- and
HGF-treated group; n 3 wells counted for CM and CM plus antibody (CMAb) groups; asterisks indicate statistical differences
versus SFM and CMAb conditions; p 0.001]. Scale bars: (in A) A–D, 80m; (in A, inset) A, B, insets, 24m.
Figure 4. Primary GnRH-1 neurons express tPA during their migration. A, Photomicrograph of a nasal explant maintained for
4.5div.NumerousGnRH-1-likeneurons (phase-bright cells) canbe seen in theperipheryof theexplant. Thedashed linedelineates
the main nasal tissue from the periphery of the explant. Bipolar GnRH-1-like cells in the periphery of the explant are identified in
situ (B, arrow)and removed (C, arrow)with amicrocapillary pipette.D, Representativegel of PCRproducts fromsingle-cell RT-PCR
performed on GnRH-1 cells (4.5 and 28 div) extracted from the explant periphery. Products produced by PCR amplification using
L19-, GnRH-1-, tPA-, and uPA-specific primers. tPA transcriptwas detected in primary GnRH-1 neurons at 4.5 div (80%) but not at
28 div. uPA transcript was not detected in GnRH-1 neurons at either 4.5 or 28 div. No specific band was detected in water
(W). B, E17.5 brain, positive control. E, Nasal explant at 4.5 div double stained for GnRH-1 (red; arrows) and tPA (green).
Inset, A single confocal plane showing a GnRH-1-positive cell colabeled with tPA. Scale bars: A, 100 m; (in B) B, C, 10
m; E, 50m; E, inset, 5m.
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GnRH-1 cells (Fig. 6B–D, arrowheads, insets) and the
peripherin-fiber network in the periphery of the explant (Fig.
6C,D, arrows, insets). Quantitative assessment of olfactory fiber
outgrowth revealed a significant reduction in the maximum dis-
tance from the border of the explant after treatment with anti-
HGF ( p  0.001; control, 1188  47 m; n  17; anti-HGF
treatment, 996 95m;n 16). The complex nature of the fiber
network prevented quantification of individual fiber lengths.
Therefore, the observed reduced distance of the peripherin-
positive fiber bundles could be the result of a defect in olfactory
axon elongation or of an altered orientation of the olfactory
axons.
For GnRH-1 cell migrational measurements, a caliber with a
series of concentric arcs separated by a uniform distance (200
m)was overlaid on the digitized image, and the number of cells
in each zone was counted (Fig. 6A). In addition to changes in
olfactory axons, GnRH-1 neuronswere closer to the border of the
explant in the anti-HGF treated group compared with controls
(Fig. 6B–D) ( p  0.005). In control explants, 14% of the entire
GnRH-1 cell population was dispersed beyond zone 4 (	600m
from the border of the explant tissue mass), whereas when ex-
plants received anti-HGF, only 6% of GnRH-1 neuronsmigrated
	600 m into the periphery. In treated explants, GnRH-1 neu-
rons also displayed an abnormal migratory behavior. In control
conditions, the majority of migrating cells were uniformly ori-
ented in a proximal-to-distal direction
(Fig. 6C, inset), whereas in the presence of
HGF antibody, such polarized direction
was lost, andGnRH-1 neurons orientation
appeared more random (Fig. 6D, inset).
Although “randomly” oriented, the mi-
grating neurons maintained contact with
peripherin-positive fibers, which also ap-
peared more entwined and less direction-
ally oriented after anti-HGF treatment
(Fig. 6C,D). Thus, we were unable to de-
termine whether the loss of orientation of
GnRH-1 neurons was attributable to cell-
autonomous mechanisms or instead di-
rectly dependent on altered outgrowth of
olfactory axons.
Exogenous HGF increases GnRH-1 cell
migration in nasal explants
We next evaluated the effect of exogenous
HGF onGnRH-1 cell migration and/or on
olfactory axon outgrowth. HGF treatment
did not affect the total number of GnRH-1
neurons compared with controls (control,
221 46; n 11; HGF-treated, 204 19;
n 10). However, a significant shift in the
location of GnRH-1 neurons was noted in
HGF-treated cultures (Fig. 7) ( p 0.001).
In this group, 21% of GnRH-1 neurons in
the periphery of the explant migrated be-
yond zone 5 (	 800 m from the edge of
themain tissuemass), comparedwith con-
trols, which displayed only 8% of the
GnRH-1 population in this same com-
partment. To determinewhetherHGFhad
an effect on olfactory axon outgrowth as
well, the mean maximum network out-
growth of peripherin fibers was analyzed.
Quantitative analysis revealed that the extent of fiber outgrowth
was similar among HGF-treated and control explants (control,
olfactory axon outgrowth: 1215 57 m; n 11; HGF-treated,
olfactory axon outgrowth: 1292 48; n 10), and directionality
was maintained in all explant groups (data not shown).
HGF is a guidance signal for migrating GnRH-1 neurons
The HGF expression pattern suggests that GnRH-1 neurons may
follow this diffusible molecule as they move from the VNO to-
ward the nasal/forebrain junction. If this were the case, then ad-
dition of an exogenous source of HGF in a direction opposite to
the normal migratory pathway (i.e., the rostral tip of the nose)
should disrupt or delay GnRH-1 neuronal migration. To test this
hypothesis, functional experiments were performed by cocultur-
ing for 24 h cell aggregates ofHGF-transfected cells, togetherwith
parasagittal slices of whole heads of E12.5 mice. This embryonic
age corresponds to a stage in which GnRH-1 neurons span from
the VNO to the nasal/forebrain junction, on their way into the
CNS (Wray, 2002).
MDCK EGFP–HGF stable transfectants were generated using
the Tet-Off expression system (Gossen and Bujard, 1992). Clones
were screened through EGFP imaging (Fig. 8A, top left). When
cells were cultured in the presence of 1 g/ml Dox, EGFP and
HGF expressions were turned off (Fig. 8A, top right).
To verify HGF biosynthesis in these cells, total extracts were
Figure 6. Neutralization of endogenous HGF alters GnRH-1 cell motility and olfactory axon outgrowth. A, Photomicrograph of
nasal explant immunocytochemically labeled for GnRH-1 (brown) and peripherin (blue) at 7 div. Images were digitized and
overlaid on a calibration meter composed of concentric arcs. B, Quantitative analysis of GnRH-1 cell distribution in the periphery
of the explant after anti-HGF treatment. Fewer GnRH-1 neurons were located in the farthest zones of the anti-HGF-treated
explants compared with controls (0.6–1 mm away from the border of the explant; *p 0.001; n 20 and 21 for control and
anti-HGF-treated groups, respectively), whereas there was a concomitant accumulation of GnRH-1 cells closer to the explant
tissue mass. C, D, Photomicrograph of nasal explants immunocytochemically labeled for GnRH-1 (arrowheads) and peripherin
(arrows) at 7 div in control conditions (C) and after anti-HGF treatment (D). Anti-HGF treatment prevented GnRH-1 cells and
olfactory fibers frommoving into theperiphery but stayed closer to theborder of the explant tissuemass. After treatment, GnRH-1
cells displayed an atypical migratory behavior, losing the proximal (P)-to-distal (D) orientation detected in control explants, and
the olfactory fiber network also appeared highly disorganized (C and D, insets and schematics). The dashed lines indicate the
border of the explant tissue mass. Scale bar (in A): A, C, D, 200m; C, D, insets, 20m.
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run under nonreducing conditions and immunoblotted with
anti-VSVG (Fig. 8B). Tet-Off MDCK cells expressing EGFP and
HGF were grown in the absence (lane 1) or presence (lane 2) of
Dox. Tet-Off MDCK cells expressing only EGFP were used as
negative control (lane 3). Transfected HGFwas identified as pro-
HGF inside the cells and was expressed only in the absence of
Dox. In addition, the ability to produce and release active HGF in
the culturemediumwas tested by using the scatter assay. CMwas
collected from Tet-Off cells grown with or without Dox for sev-
eral days, diluted 1:1 with fresh culture medium, and applied
onto MDCK cells (Fig. 8A, bottom).
HGF-releasing cell aggregates were placed at the tip of the
nose (Fig. 9C,D). The mean numbers of cells that were GnRH-1
immunoreactive per slice ( SEM)were 273 21 (control, 0 div;
n  6), 301  16 (control, 1 div, with Dox; n  6), 285  19
(HGF, 1 div, without Dox; n 4), with no significant difference
among groups ( p 	 0.05) (Fig. 9B). The changing positions of
GnRH-1-ir neurons from nasal compartment to the CNS be-
tween day 0 and day 1 control slices provided evidence of migra-
tion in vitro (Fig. 9B). Slices grown for 1 div in the presence of
EGFP–HGF cell aggregates silenced with Dox showed a broad
distribution of GnRH-1 cells from the nasal compartment (Fig.
9E, arrowheads) to the basal forebrain (Fig. 9E, arrows). GnRH-1
neurons migrating through the nasal mesenchyme displayed a
bipolar morphology and were visible as streams of neurons di-
rected toward the cribriform plate (Fig. 9E, inset). At this stage,
32% of the total GnRH-1 neurons entered the brain (Fig. 9B,E,
arrows). In contrast, GnRH-1 cells displayed an atypical migra-
tory behavior when embryonic slices were
cocultured with EGFP–HGF-expressing
cell aggregates cultured in the absence of
Dox (Fig. 9D,F). The vast majority of
GnRH-1 neurons (90%) did not reach the
forebrain (Fig. 9B,F, arrowheads), as a re-
sult of accumulation in the nasal compart-
ment (Fig. 9F, inset). Significant differ-
ences in GnRH-1 cell distribution between
groups treated with and without Dox were
observed both in the nose and in the CNS
( p 0.05).
Intense peripherin immunoreactivity
was found on olfactory/vomeronasal ax-
ons that crossed the nasal mesenchyme
and projected into the forebrain in cul-
tures both with and without Dox (Fig.
9G,H). The olfactory fiber network in the
nose as well as in the forebrain did not ap-
pear to be disrupted when HGF-releasing
cell aggregates were cocultured with em-
bryonic slice cultures (Fig. 9G,H).
Fewer GnRH-1 neurons are present in
the tPA/uPA deficient mice
Early embryonic lethality of met mutants
has prevented in vivo studies on thesemice
to determine the functional role of HGF in
GnRH-1 neuron development (Bladt et al., 1995; Schmidt et al.,
1995; Uehara et al., 1995). Therefore, we investigated the effect of
deletion of tPA and uPA genes on the number of GnRH-1 neu-
rons in adult brains. These serine proteases have been shown to
activate the progrowth factor HGF (Mars et al., 1993).Moreover,
previous studies showed that mice with combined deficiencies of
tPA and uPA are subfertile and display reduced gonadotropin-
induced ovulation efficiency (Carmeliet et al., 1994; Leonardsson
et al., 1995). The total number of GnRH-1 neurons was com-
pared in 60- to 90-d-old WT male mice (n  3) and age and
sex-matched double-KO mice for tPA and uPA genes (n  3).
Analysis revealed a significant reduction in GnRH-1 cell number
in the brains of mutants compared with WT (WT, 642  16;
tPA/:uPA/, 422 24; p 0.001). A reduction of35%was
Figure7. ExogenousHGF increasesGnRH-1 cellmotility innasal explants. Quantitative anal-
ysis of GnRH-1 cellmigrationafter exogenous applicationofHGF. The sameanalysis described in
Figure 4 was used in these experiments. HGF (25 ng/ml) applied from 3 to 6 div significantly
increased, at 7 div, the number of GnRH-1 cells reaching the farthest zones compared with
controls (n 11 control; n 10 HGF-treated group; *p 0.001).
Figure 8. Characterization of the Tet-OffMDCK cell line.A, Photomicrograph of the Tet-OffMDCK cell line expressing EGFP and
HGF. Note that EGFP is highly expressed by 70–80% of cells (top left). Cells were cultured in the absence or presence of 1g/ml
Dox.When cells are shifted toDox-containingmedium, EGFP expression is turned offwithin 24h after the shift (top right). Bottom
left, MDCK scatter after a 24 h incubation with CM collected from Tet-Off MDCK EGFP–HGF stable clone, grown in the absence of
Dox. Bottom right, MDCK cells are organized in discrete, compact colonies after exposure of CM collected from with Dox Tet-Off
cells. B, Western blot analysis for HGF in total extracts of MDCK cells expressing tagged HGF. Total extracts were run under
nonreducing conditions and immunoblotted with anti-VSVG antibody. Tet-Off MDCK cells expressing EGFP and HGF were grown
in the absence (lane 1) or presence (lane 2) of Dox. Tet-Off MDCK cells expressing only EGFPwere used as a negative control (lane
3). Transfected HGFwas identified as pro-HGF inside the cells (100 kDa) andwas expressed only in the absence of Dox. Scale bars:
A, top, 5m; A, bottom, 20m.
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found in the KO animals. Figure 10, A and
B, shows representative stainings for
GnRH-1 neurons (arrows, single GnRH-1
cells; arrowhead, cluster of GnRH-1 cells)
in the diagonal band of Broca (dbb) of the
hypothalamus of WT and double-KO
mice. At this level, numerous GnRH-1
neurons are normally detected (Fig. 10A).
In contrast, few GnRH-1 neurons are de-
tected at this level in KO mice (Fig. 10B).
The median eminence of tPA/:uPA/
brains was also sparsely innervated by
GnRH-1-immunoreactive terminals (Fig.
10D, arrowhead, inset) compared with
WT (Fig. 10C, arrowhead, inset).
Discussion
Development of the olfactory and
GnRH-1 neuroendocrine systems is inti-
mately entwined in early embryogenesis
(Wray, 2002). The mechanisms directing
the initiation of cell migration and olfac-
tory axon extension from nose to fore-
brain are unclear but likely require specific
motogenic and guidance cues. In this re-
port, we show that HGF and Met are
expressed in a spatiotemporal pattern to
impact GnRH-1/olfactory system devel-
opment. Functional analysis supports the
notion that HGF plays an important role
in regulating GnRH-1 neuronal migration
across nasal regions toward the CNS dur-
ing embryogenesis.
Previous studies have shown that c-met
and tPAmRNAs are expressed in olfactory
epithelium, whereas HGF transcript local-
ized to the surrounding nasalmesenchyme
starting at E11 in mouse (Sonnenberg et
al., 1993; Thewke and Seeds, 1996), when
Figure 9. HGF acts as a guidance signal for GnRH-1 neuronal migration during embryogenesis. A, Schematic of an E12.5 head
slice culture [fb, presumptive VNO, and tongue (t) are depicted]. A dashed line indicates the boundary between nose and brain.
Aggregates of Tet-Off cells (black oval), cultured in the presence or absence of Dox, were placed at the rostral tip of the nose of
E12.5 slice cultures. B, Quantitative analysis of GnRH-1 cell distribution in the nasal compartment and in the CNS of E12.5 slice
cultures at 0 div [control (cntr); n 6] and grown in vitro for 24 hwith EGFP–HGF cell aggregates (with Dox, n 6; without Dox,
4
n 4). Analysis of GnRH-1 neurons location revealed an ac-
cumulation of cells in the nasal region when organotypic
slices were cocultured with HGF-releasing cell aggregates. C,
E, NormalmigratingGnRH-1neurons in slices coculturedwith
Tet-Off EGFP–HGF cell line in the presence of Dox. Note that
EGFP is turned off in the cell aggregate. GnRH-1-positive cells
migrate in chains through the nasal compartment (arrow-
heads) and enter the brain (arrows). E, Inset, A high-power
view of typical migratory GnRH-1 neurons crossing the nasal
mesenchyme characterized by a bipolarmorphology and by a
chain-like organization. D, When cocultures were performed
with transfected cells shifted to a medium without Dox,
GnRH-1 neurons accumulate in the nasal region and fail to
enter the brain (B, D, F ). The inset in F shows the abnormal
phenotype of GnRH-1 neurons in these cultures. Many cells
appear round and lack a leading and a trailing process, typical
of migrating cells. G, H, Antibodies to peripherin react with
vomeronasal and olfactory axons that extend along the nasal
mesenchyme to the forebrain. No difference in the organiza-
tion of the fiber network was evident among the treatment
conditions (G,withDox;H,withoutDox). bfb, Basal forebrain.
Scale bars: (in C) C, D, 300 m; (in E) E–H, 150 m; (in E,
inset) E, F, insets, 20m.
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the GnRH-1/olfactory systems are in their
initial stages of development. Here, bio-
logically active HGF and Met protein ex-
pression was documented in nasal regions
as early as E12. The majority of GnRH-1
neurons located in the nasal compartment
were found to be Met immunopositive
with expression correlatedwithmigration.
Using RT-PCR, c-met mRNA was de-
tected in laser-captured tissues of OE and
VNO at E14.5, confirming previous in situ
hybridization studies (Sonnenberg et al.,
1993; Thewke and Seeds, 1996). More-
over, immunohistochemistry coupled
with confocal microscopy revealed that
Met protein is expressed along NCAM-
positive olfactory fibers during embryonic
development. Thus, the spatiotemporal
expression of HGF and Met receptor in
nasal regions correlates with migration of
GnRH-1 neurons toward the CNS and de-
velopment of the olfactory sensory system.
To determine the functional role of
HGF in the development of the GnRH-1
system, we took advantage of an in vitro
model, nasal explants, which has been suc-
cessfully used for other functional studies
(Fueshko et al., 1998; Kramer and Wray,
2000; Giacobini et al., 2004). These ex-
plantsmaintain large numbers of GnRH-1
neurons, migrating in a manner similar to
that observed in vivo, as well as directed
olfactory axon outgrowth (Fueshko and
Wray, 1994). Expression of Met in the ol-
factory system and in primary GnRH-1
neurons in nasal explants was similar to
that observed in vivo. HGF was expressed
as early as 3 div, a stage of active cell mi-
gration and olfactory axon outgrowth, and the expression paral-
leled HGF transcript distribution described previously in vivo
(Sonnenberg et al., 1993; Thewke and Seeds, 1996). HGF immu-
noreactivity was observed in the olfactory mucosa surrounding
the OE, in the nasal midline cartilage, and in the frontonasal
mesenchyme, which is the region apposed to the ventromedial
forebrain before dissection. Olfactory pathway development de-
pends on induction between the frontonasal mesenchyme and
adjacent olfactory epithelia (LaMantia et al., 2000). Interestingly,
HGF mRNA has been shown to be unevenly distributed in the
nasal mesenchyme during embryonic development, being ex-
pressed in a gradient with higher levels toward the forebrain
(Sonnenberg et al., 1993). A similar expression pattern has been
shown for SDF-1 in these regions (Schwarting et al., 2006). This
transcript is expressed in a steep gradient in the developing nasal
mesenchyme, being lower proximal to the VNO and greater at
the nasal/forebrain junction. SDF-1 was shown to be important
for the migration of GnRH-1 neurons (Toba et al., 2004;
Schwarting et al., 2006). Other studies demonstrated that SDF-1
andHGF regulate recruitment ofmesenchymal stem cells toward
damaged tissues (Ji et al., 2004; Urbanek et al., 2005) and that
HGF chemotactic response could be potentiated by SDF-1 (Son
et al., 2006). Similarly, muscle progenitor cells migrate toward
SDF-1-expressing targets with CXCR4 (CXC receptor 4), the
SDF-1 receptor, and Gab1 [Grb2 (growth factor receptor-bound
protein 2)-associated binding protein 1], the adaptor molecule
that transmits Met signaling, cooperating to control this process
(Vasyutina et al., 2005). Thus, we cannot rule out cross talk be-
tween the HGF and SDF-1 signaling pathways in regulating di-
rectedmigration of GnRH-1 neurons from theVNO to the brain.
In addition to Met, primary GnRH-1 neurons express tPA.
Interestingly, this expression pattern correlatedwithmigration of
these cells, being downregulated in postmigratory GnRH-1 neu-
rons. Previous studies showed that tPA transcript is expressed in
migrating neurons crossing the nasal mesenchyme during early
stages of embryonic development (Friedman and Seeds, 1994).
Here, we suggest that at least part of these cells are GnRH-1
neurons and that these cells display the molecular machinery to
activate HGF in the immediate vicinity of its c-met receptor, thus
initiating a cell signaling cascade that influences cell movement.
Our in vitro experiments demonstrated that biologically active
HGF was released into the medium of nasal explants. In the mo-
togenic assay, this medium induced a scatter response in MDCK
cells, whichwas blocked byHGF-neutralizing antibody.HGFwas
released into the nasal explant medium in the initial period of
GnRH-1 neuronal migration and olfactory axon elongation.
Anti-HGF treatment significantly stunted GnRH-1 migratory
behavior and olfactory axon outgrowth (elongation or orienta-
tion), supporting endogenous HGF acting as a motogen on
GnRH-1 neurons and a growth promoter for olfactory axons.
Figure 10. GnRH-1 neuronal population is reduced in tPA/:uPA/ mice. A, GnRH-1-immunoreactive cell bodies are
located principallywithin the preoptic area and dbb of theWTmouse brain (arrows, single GnRH-1 neurons; arrowhead, cluster of
GnRH-1neurons in the dbb).B, Amajor loss of GnRH-1neuronswas found in the brain of adult double-KOmice (arrows and inset).
Note that the level of the section represented in B is comparable with A. The principal fiber projections of GnRH-1 neurons are to
themedianeminence (me;C, arrowhead), and this region showedadramatic loss ofGnRH-1 fibers inmutantmice (D, arrowhead).
Insets,High-power viewsof themedianeminence inWTandKObrains. Scalebars: (inA)A–D, 100m; (inA, inset) insets, 20m.
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When GnRH-1 cells were subject to exogenous uniform HGF
concentrations, the cells didmigrate farther and kept their spatial
orientation. No effect was observed in terms of olfactory axon
growth, in contrast with olfactory axon changes detected in the
blocking-function experiments. This apparent discrepancy may
result because olfactory axon extension cannot be stimulated
above an intrinsic limit or a limit imposed by general fibroblast
outgrowth. Therefore, exogenous HGF might be insufficient to
promote additional elongation of olfactory axons.
After HGF exposure, parallel changes were not detected in the
GnRH-1 and olfactory system. Thus, the changes observed in
GnRH-1 cell migration do not appear to be an effect dependent
on alterations in olfactory axon outgrowth and suggest that the
HGF effect on the motility of GnRH-1 neurons is in fact cell
autonomous. It is important to note that, although anti-HGF
treatment induced a striking accumulation of cells and olfactory
fibers closer to the nasal explant tissue mass, it did not prevent
GnRH-1 cells and peripherin-positive fibers from moving/ex-
tending into the periphery of the explant. Likely, residual HGF
and perhaps other factors present in the nasal explants contribute
to the initiation of cell movement and olfactory axon outgrowth.
We showed previously that HGF acts as a chemoattractant for
immortalized GnRH-1 cells (Giacobini et al., 2002). Organotypic
slices have been shown previously to contain the conditions nec-
essary to allow GnRH-1migration from the developing olfactory
system to the basal forebrain while keeping intact their migratory
route (Tobet et al., 1996). Thus, retained in these slices are the
guidance cues for GnRH-1/olfactory system development that
are clearly lacking in immortalized cells. In addition, some phe-
notypic/behavioral traits of the cell lines could be a consequence
of the immortalization procedure whichmay alter the expression
pattern and the activity of such cells (Martinez de la Escalera and
Clapp, 2001). Thus, to evaluate whether HGF acts as a guidance
cue during the migration of primary GnRH-1 neurons, we used
tissue slices prepared from mouse embryos (Tobet et al., 1996;
Bless et al., 2000). Tissue slices thatmaintain connection between
forebrain and nasal compartment were generated from E12.5
whole heads. Embryonic sliceswere coculturedwith aggregates of
EGFP–HGF-transfected cells. In these experiments, after 1 d in
vitro, GnRH-1 neurons accumulated in the nasal region when
slices were cocultured with HGF-releasing transfected cell aggre-
gates placed in an opposite direction with respect to the normal
GnRH-1 migratory pathway.
The disruption of GnRH-1 cell motility observed in these ex-
periments may result from their exposure to two attractive HGF
gradients (one endogenous and one exogenous) acting from two
opposite sites or from threshold concentrations of exogenous
HGF, which fail to generate a motogenic response. In these in
vitro coculture experiments, no alterations were observed in
peripherin-positive olfactory/vomeronasal nerve axons among
treatment groups, suggesting that the observed HGF-induced
GnRH-1 neuronal migration defect is cell autonomous. How-
ever, it should also be noted that, at E12.5, olfactory fibers could
no longer be sensitive to HGF stimulation, as they have started to
contact their tissue target (i.e., the presumptive olfactory bulbs).
In fact, it is known that at E11 in themouse, axons begin to extend
from the OE, forming small fascicles which pierce the basal lam-
ina (Marin-Padilla and Amieva, 1989).
HGF-induced activity requires proteolytic processing, which
is, at least in part, operated through enzymatic cleavage by PAs
(Naldini et al., 1992; Mars et al., 1993). Mice carrying combined
deficiencies for tPA and uPA genes are subfertile (Carmeliet et al.,
1994), consistentwith the hypothesis that the lack of tPA anduPA
genes prevents active HGF from promoting GnRH-1 neuronal
migration into the forebrain. To examine this possibility, the
number of GnRH-1 neurons in adult brains of tPA/:uPA/
mice was compared with those of WT animals. The lack of tPA
and uPA clearly affected the size of the GnRH-1 neuronal popu-
lation, decreasing the number of GnRH-1 cells detected in brain.
Whether this effect is directly related to loss of active HGF on
GnRH-1 neurons or to additional mechanisms affecting GnRH-1
differentiation or cell survival will require additional investigations.
Very little is known about early interactions between migrat-
ing GnRH-1 neurons and the nasal mesenchyme, which lead to
proper initial movement from the presumptive VNO toward the
rostral forebrain.Our results are consistent with a role forHGF as
amotogen as well as a chemotactic signal for developingGnRH-1
neurons, acting to positively modulate cell–cell and cell–ECM
interactions during the early aspects of their migratory process.
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